Discover open access scientific publications

Safety Profile and Clinical Activity of Multiple Subcutaneous Doses of MEDI-528, a Humanized Anti-Interleukin-9 Monoclonal Antibody, in Two Randomized Phase 2a Studies in Subjects With Asthma